Multivariate analysis of factors that predicted severe complications in the entire population (MM and other cancers) (n = 190)
Variable . | No. of patients with complication (%); total = 36 . | No. of patients without complication (%); total = 154 . | P . | Odds ratio (95% CI) . |
|---|---|---|---|---|
| Before therapy | ||||
| Renal failure | 20 (56) | 26 (17) | .0001 | 8.3 (2.9-23.7) |
| LDH* | 15 (42) | 34 (22) | .017 | 3.4 (1.3-9.5) |
| After therapy | ||||
| No mucositis | 6 (17) | 68 (47) | .029 | 1 |
| Mucositis grade I/II | 13 (37) | 48 (33) | .013 | 5.7 (1.4-22.3) |
| Mucositis grade III/IV | 16 (46) | 30 (21) | .020 | 5.2 (1.3-20.6) |
Variable . | No. of patients with complication (%); total = 36 . | No. of patients without complication (%); total = 154 . | P . | Odds ratio (95% CI) . |
|---|---|---|---|---|
| Before therapy | ||||
| Renal failure | 20 (56) | 26 (17) | .0001 | 8.3 (2.9-23.7) |
| LDH* | 15 (42) | 34 (22) | .017 | 3.4 (1.3-9.5) |
| After therapy | ||||
| No mucositis | 6 (17) | 68 (47) | .029 | 1 |
| Mucositis grade I/II | 13 (37) | 48 (33) | .013 | 5.7 (1.4-22.3) |
| Mucositis grade III/IV | 16 (46) | 30 (21) | .020 | 5.2 (1.3-20.6) |
Increased serum LDH (> 190 IU/L).